Looser regulations around consumer-grade wearable devices could be a "path to ROI" for health systems—or a "double-edged ...
As employers continue to navigate evolving workplace challenges, the webinar will focus on the meaning of a drug-free workplace in 2026, including prevention strategies, policy considerations, and the ...
Although synthetic astaxanthin remains the most common source for achieving desired salmon coloration, natural alternatives have been gaining popularity. As the U.S. Food and Drug Administration (FDA) ...
Market opportunities arise in providing solutions for cGMP software verification and validation, addressing increased FDA scrutiny. Demand exists for expertise in FDA guidelines, risk management ...
How the industry can break the larger goal of full supply chain traceability into manageable, achievable steps ...
Nxera Pharma Co. Ltd ('Nxera”; TSE 4565) will announce its earnings results and present operational highlights for the year ...
In this free webinar, learn how modeling and simulation can help navigate the Animal Rule in drug development. Attendees will gain insight into when the Animal Rule is appropriate to use for drug ...
Join Catherine Tyner, Head of Clinical Strategy, AG Mednet; and Craig McLendon, former Vice President, Adjudication, ...
In 2025, the U.S. Food and Drug Administration (FDA or the Agency) issued a surprising number of enforcement letters to ...
FDA Accepts Investigational New Drug (IND) Application for COMP360 for the treatment of post-traumatic stress disorder (PTSD), enabling initiation of late-stage trial Compass continues to advance ...
FDA seeks industry input on gluten labelling to protect coeliac consumers and improve transparency across US packaged food markets worldwide.
The FDA has issued a fresh warning after recalled canned tuna linked to botulism risk was accidentally redistributed to US ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results